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Streptococcus oralis is an oral commensal bacterium and a leading cause of sub-acute infective 
endocarditis (IE). Little is known of the mechanisms by which this bacterium colonizes the oral 
cavity and causes sub-acute IE. A crucial step in both processes is adhesion to host surfaces, yet 
no adhesion mechanisms have been defined for S. oralis subsp. dentisani. Electron microscopy 
images of S. oralis subsp. dentisani endocarditis isolates identified dense mono-lateral fibrils. 
Other streptococcal species have been shown to bind oral and IE relevant host surfaces, 
including oral epithelial cells, saliva and platelets, via serine-rich repeat proteins (SRRPs), a 
family of bacterial adhesins which typically form fine fibrils evenly distributed over the bacterial 
surface. However, S. cristatus has dense mono-lateral fibrils associated with an SRRP. This led 
to the hypothesis that S. oralis subsp. dentisani encodes one or more SRRPs that produce mono-
lateral fibrils and act as adhesins. Analysis of a genome sequenced S. oralis subsp. dentisani 
isolate revealed three genes encoding putative SRRPs. A panel of SRRP mutants was generated 
and showed that each putative SRRP locus produces mono-lateral fibrils. The secondary 
structures of SRRPs are composed of two serine-repeat regions flanking a non-repeat region 
(NRR). Receptors for members of the SRRP family differ based on domains within the NRR. 
Structural predictions of the NRR suggest that two of these SRRPs, FapA and FapB, play a role 
in biofilm formation and intra- and interspecies interactions. Initial experiments suggest that 
FapA and FapB contribute to the auto-aggregation of this isolate. The FapC NRR contains 
predicted domains previously shown to bind sialic acid in other SRRPs. FapC mutants showed a 
significant reduction in adherence to saliva, which is heavily sialylated, suggesting FapC is 
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Infective endocarditis (IE) is responsible for one in every thousand hospital admissions in the 
United States (1). An infection of the heart endocardium, IE is a particularly devastating disease, 
resulting in a 10% mortality rate in-hospital and a 40% mortality rate a year post diagnosis (2). 
Although IE is clearly a large health concern in the U.S., the incidence of IE has not decreased in 
the past 30 years (2). Therefore, it is critical that we better understand the factors and pathways 
by which IE manifests, so we may better design and implement new preventative and therapeutic 
strategies.  
Infective endocarditis is split into two types, each characterized by their pathogenesis. Acute IE 
frequently occurs in intravenous drug users and is characterized by a rapid onset (1). No pre-
existing heart valve damage is necessary in the pathogenesis of acute IE. Alternatively, sub-acute 
IE requires pre-existing heart valve damage before infection can occur. Blood-borne bacteria 
may then adhere to this damage and form a nidus. Over time, a vegetation may begin to grow, 
impeding proper heart function and posing the potential of breaking off and causing a stroke (3). 
Symptoms of sub-acute IE include fever, night sweats, and weight loss (4). Because symptoms 
are largely non-specific, sub-acute IE can go undetected for long periods of time, making it 
particularly difficult to treat those afflicted as the infection has grown over time. As IE is most 
prevalent in elderly populations, rates of IE will increase as our population ages, making it 
important we find alternative methods of detection and treatment now (5).  
Subacute IE is frequently caused by Viridans group streptococci, of which Streptococcus oralis 
is a member (4). Streptococcus oralis is an oral commensal and a leading cause of subacute IE 
(6, 7). Improvements in genomics, such as multilocus sequence analysis, has led to the addition 
of Streptococcus dentisani, Streptococcus mitis biovar 2, and Streptococcus tigurinus to the S. 
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oralis taxon, which was then divided into three subspecies: S. oralis subsp. oralis, S. oralis 
subsp. tigurinis and S. oralis subsp. dentisani (8, 9). All three of these subspecies have been 
isolated from the blood of IE patients (6, 10-12). Adhesion to host surfaces and receptors is 
critical in both the oral cavity during colonization and the heart endocardium during IE. 
Although this bacterium is a primary cause of subacute IE, very little is known of the 
mechanisms by which it adheres to host surfaces during colonization or IE. It is therefore critical 
we gain an understanding of the methods and mechanisms by which these bacteria bind to host 
surfaces, so we may identify prominent drug targets and potential therapeutic treatments.  
Serine-rich repeat proteins (SRRPs) are a family of bacterial adhesins which can mediate binding 
to several host and bacterial surfaces in pathogenic and commensal Gram-positive organisms 
(13-18). SRRPs are named for their two heavily glycosylated serine-rich repeats (SRRs) which 
flank a non-repeat region (NRR). All defined SRRP-receptor interactions identified thus far have 
been shown to be facilitated through the modular NRR, located within the N-terminal region of 
the protein (14). Previously identified receptors include sialic acid, keratins, fibrinogen, DNA, 
rhamnogalacturonan I, polygalacturonic acid and chondroitin sulfate (14-16, 19-21). Most 
SRRPs are characterized to bind a single receptor, however, pneumococcal SRRP PsrP has been 
shown to bind multiple receptors (20-22). 
Bacterial SRRPs have also been implicated in inter- and intraspecies interactions. Streptococcus 
cristatus SRRP SrpA has been shown to be required for binding to Fusobacterium nucleatum 
and Corynebacterium matruchotti in vitro (23-25). It has also been reported that pneumococcal 
SRRP PsrP plays a role in intraspecies interactions which promote bacterial aggregation in the 
nasopharynx and lungs of infected mice, as well as in models of mature biofilms (26). 
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Additionally, Staphylococcus aureus SRRP SraP and Streptococcus gordonii SRRP GspB were 
shown to be involved in intraspecies bacterial adhesion by promoting bacterial aggregation (26).    
In all SRRPs described, a single genomic region encodes for the SRRP(s) and proteins required 
for glycosylation (GftA/B) and secretion (SecA2/Y2) of the SRRP (14, 27, 28). The cytosolic O-
glycosyltransferase, GftA/B, is a complex of GftA and GftB subunits. GftA/B glycosylates 
serine and threonine residues of translated SRRP precursors, which is necessary for stability of 
the SRRP (14, 29). The SecA2/Y2 system is proposed to be dedicated to the secretion of SRRPs 
(27). The SRRP is targeted to the accessory secretion system via an atypical N-terminal 90 
amino acid secretion signal. Different streptococcal species, and even in some cases different 
strains, encode unique SRRPs. Most streptococcal species encode for and produce a single 
SRRP, although there have been cases of streptococcal species encoding for multiple SRRPs, 
such as Streptococcus salivarius, which was found to encode for three SRRPs (13). Additionally, 
some strains of Lactobacillus have been reported to encode for multiple SRRPs (30). 
Although the structure and appearance of SRRPs has received limited investigation, SRRPs are 
typically associated with thin fibrils that are evenly distributed across of the bacterial surface (13, 
14, 28, 31-33). Some deviations exist, including Streptococcus cristatus, which has been 
reported to produce mono-lateral, or one-sided, tufts made up of fibrils of two lengths, long and 
short (23, 25, 34). A variant of this strain lacking the 5’ end of the gene encoding for the SRRP 
SrpA no longer displayed the longer of the two fibrils, linking this SRRP with the production of 
the long fibrils (23, 35, 36).    
Streptococcus oralis subsp. oralis IE isolates have previously been reported to encode for SRRP 
Fap1, which was found to be required for binding to both terminal sialic acid and cryptic β-1,4 
linked galactose revealed by S. oralis neuraminidase (17). However, fap1 is not present in S. 
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oralis subsp. dentisani isolate F0392, meaning adhesion of this isolate to host surfaces must be 
facilitated via a distinct SRRP or an SRRP-independent mechanism.    
The primary goal of this study was to identify and characterize the dense mono-lateral fibrils 
imaged on S. oralis subsp. dentisani isolate F0392. Because of its similarity in appearance to the 
SRRP expressing S. cristatus, the presence of multiple SRRP encoding open-reading frames in 
the F0392 genome and the fact that all identified functions of SRRPs have centered around 
bacterial adhesion, we hypothesized that S. oralis subsp. dentisani isolate F0392 encodes for 
multiple SRRPs which produce mono-lateral fibrils and act as adhesins. As S. oralis is a primary 
cause of sub-acute IE, we hope study of the adhesins of this organism may yield invaluable data 
leading to a greater insight of the mechanisms by which this bacterium colonizes the oral cavity 
and causes sub-acute IE. Knowledge of these mechanisms will likely identify new drug targets in 
IE pathogenesis and ultimately ease the burden of IE.    
METHODS 
Bacterial strains, culture, media, and chemicals 
Wild-type and genetically altered strains of S. oralis subsp. dentisani are listed in Table 1. S. 
oralis subsp. dentisani was grown overnight at 37 oC and 5% CO2 on tryptic soy agar plates 
supplemented with 5% sheep’s blood (Becton, Dickinson and Co., Sparks, MD) or tryptic soy 
(TS) agar plates spread with 5000 U catalase (Worthington Biochemical Corporation, Lakewood, 
NJ) prior to plating. Broth cultures were grown statically in Todd-Hewitt broth (Becton, 
Dickinson and Co.) supplemented with 0.2% w/v yeast extract (Becton, Dickinson and Co.) 
(THY). C + Y media with 5% yeast extract (C+Y) pH 8.0 was used for transformations (37). 
Mutant S. oralis strains were selected on TS agar plates supplemented with spectinomycin (200 
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µg/mL), erythromycin (1 µg/mL), kanamycin (500 µg/mL), streptomycin (200 µg/mL) or 
chloramphenicol (2.5 µg/mL) as appropriate.  
Escherichia coli were grown at 120 rpm in Luria-Bertani (LB) broth or LB agar plates.  E. coli 
containing cloned plasmids were selected using media supplemented with spectinomycin (50 
µg/mL), erythromycin (200 µg/mL), kanamycin (50 µg/mL), chloramphenicol (30 µg/mL) or 
ampicillin (100 µg/mL) as appropriate (Thermo Fisher Scientific).  
Unless otherwise specified, all chemicals, substrates, and enzymes were purchased from Sigma-
Aldrich (St. Louis, MO). 
Genomic DNA Prep 
S. oralis subsp. dentisani wild-type and mutant DNA was isolated by first growing strains in 
THY to OD600 = 0.6 and harvesting cells by centrifugation at 4000 rpm for 10 minutes. Bacterial 
cells were then washed and resuspended in 500 µL of resuspension buffer (50 mM NaCl, 10 mM 
Tris-HCl, pH 7.4). 15 µL of mutanolysin was added and the mixture was incubated overnight in 
a 37 oC water bath. 10 µL of EDTA (0.5 M) was added followed by incubation at 37 oC for 30 
minutes. Proteinase K was added to a final concentration of 100 µg/mL and the mixture was 
incubated at 55 oC for 10 minutes. Subsequently, 40 µL of 20% N-lauryl sarcosine was added 
followed by a 10-minute incubation period. Samples were then subjected to two rounds of 
extraction with an equal volume of phenol:chloroform:isoamyl alcohol and a final extraction 
with an equal volume of chloroform. DNA was precipitated upon addition of 0.7 volumes of cold 
isopropanol. The pellet was washed twice with 70% ethanol, air-dried, and resuspended in 50 µL 
dH2O.  
Microscopy and Staining  
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S. oralis subsp. dentisani strains were imaged using a Hitachi S-4800 scanning electron 
microscope in scanning transmission mode (STEM) with a bottom-mounted electrodetector or a 
Hitachi H-7650 transmission microscope with a CCD detector (Hitachi High Technologies 
America, Schaumburg, IL). Strains were grown to OD600 = 0.3 ± 0.005, after which bacteria 
were bound to formvar coated grids stabilized with evaporated carbon film (EMS, Hatfield, PA). 
Grids were washed three times in water and negatively stained with 1% ammonium molybdate.   
Mutant Generation 
Insertion-deletion mutants were generated via allelic exchange. SecA2 mutants were generated 
by first amplifying fragments upstream and downstream of secA2 using primers E.i with E.ii and 
E.iii with E.iv respectively. A spectinomycin cassette was amplified using primers S.F. and S.R. 
These fragments were cloned into EcoRI-digested pDrive (Qiagen) via the In-Fusion EcoDry HD 
cloning kit (Clontech, Mountain View, CA) and transformed into E. coli Stellar competent cells 
(Clontech). Transformants were selected for on LB agar plates supplemented with 
spectinomycin. Constructs were confirmed via colony PCR using M13F and T7 promoter 
primers and sequencing. S. oralis subsp. dentisani was subsequently transformed by growing 
bacteria in C+Y media to OD600 = 0.12-0.2 followed by addition of 50 µL of culture to a 
transformation mixture containing 950 µL C+Y, 10 µL CaCl2 (100 mM), 2 µL competency-
stimulating peptide (1 mg/mL) and about 100 ng of purified plasmid. This mix was incubated in 
a 37 oC water bath for two hours and transformants were selected for on TS agar plates 
supplemented with spectinomycin. Mutants were confirmed using primers flanking the construct 
(E.5 and E.6). 
Serine-rich repeat protein (SRRP) mutant constructs were generated via an inverse PCR method. 
A fragment of each SRRP encoding gene was amplified using respective primer pairs (1 and 2), 
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and subsequently cloned into pJet1.2/Blunt PCR cloning vector (Thermo Fisher Scientific) and 
transformed into E. coli Stellar via In-fusion cloning. Transformants were selected on LB agar 
plates supplemented with ampicillin and confirmed via PCR. Successfully cloned plasmids were 
isolated and an inverse PCR product was generated with primers 3 and 4. The inverse PCR 
product was then blunt end ligated to either a spectinomycin, erythromycin or kanamycin 
antibiotic resistance cassette, cloned into E. coli Stellar and plated on LB agar plates 
supplemented with appropriate antibiotics. Final plasmid constructs were confirmed via PCR. 
The plasmid was subsequently transformed into S. oralis subsp. dentisani following the 
transformation protocol outlined above. Mutants were confirmed to contain the antibiotic 
cassette and thus the mutation by PCR using primers flanking the construct (5 and 6) and 
checking that the size of this PCR product was consistent with the size of the inserted fragment.  
F0392 point mutants were generated using the two-step Janus cassette system (38). Two 
overlapping fragments were amplified using primers which introduced the appropriate codon 
change (Primers 11 and 12, 13 and 14). The two fragments were then joined together via splicing 
by overlap (SOE) PCR using primers 11 and 14. This fragment was then cloned into pGex-5X-3 
via In-Fusion cloning and transformed into E. coli Stellar, generating the point mutant plasmid 
construct pGex-5X-3 FapCR837E. Transformants were selected on LB agar plates supplemented 
with ampicillin and constructs were confirmed via PCR and sequencing. To generate the Janus 
intermediate cassette (pGex-5x-3 FapC Janus), an inverse PCR product was produced using 
primers 15 and 16 and pGex-5X-3 FapCR837E as a template. The inverse PCR product was then 
blunt-end ligated to a Janus cassette (primers J.F and J.R), followed by cloning into E. coli 
Stellar and selection on LB agar plates supplemented with kanamycin. The construct was 
confirmed via PCR. Because the Janus cassette imparts streptomycin sensitivity, a streptomycin 
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resistant strain of S. oralis subsp. dentisani (F0392 Smr) is necessary for selection. F0392 Smr 
was generated by transformation with an rpsL PCR product from an Smr S. oralis strain and 
selected for on TS agar plates supplemented with streptomycin (primers R.F and R.R). F0392 
Smr was then transformed using pGex-5X-3 FapC Janus, yielding a Janus intermediate strain. 
Transformants were selected for on TS agar plates supplemented with kanamycin. Mutants were 
confirmed by PCR using primers 11 and 14. A subsequent transformation with pGex-5X-3 
FapCR837E replaced the Janus cassette with an unmarked sequence containing the arginine to 
glutamic acid point mutation. Transformants were selected for on TS agar plates supplemented 
with streptomycin and verified via PCR (Primers 11 and 14) and sequencing.  
The genetic background of all mutants was confirmed by extragenic palindromic PCR (REP 
PCR) (39). All mutants were confirmed to be absent of generalized growth defects by analyzing 
growth on rich medium. Another member of our lab also checked mutants for polarity via RT-
PCR of downstream genes.  
Expression and purification of recombinant FapC217-938 
The NRR of fapC, encoding amino acids 217-938, was amplified using primers C.18 and C.19. 
This fragment was then cloned into GST-tagged pGex-5X-3 via In-Fusion cloning, followed by 
transformation into E. coli Stellar and selection on LB agar plates supplemented with ampicillin. 
The expression construct was confirmed by PCR and sequencing. BL21 (DE3) competent E. coli 
(New England Biolabs, Ipswich, MA) were transformed using this construct. Transformants 
were selected for on LB agar plates supplemented with ampicillin. Cultures were inoculated in 
LB broth and grown at 37 oC to OD600 = 0.6-0.8. Expression was induced by the addition of 0.5 
mM IPTG. The induced culture was incubated overnight at 120 RPM, 22 oC. Cells were 
harvested by centrifugation at 5000 RPM and 4 oC for 15 minutes and resuspended in 1/10 the 
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original volume in PBS. Cells were lysed using a French Press at 24 kPa. Cell debris was 
collected by centrifugation at 10,000 rpm and 4 oC for 15 minutes and the supernatant was 
separated from the cell debris. Resuspended cell debris and supernatant were run on an SDS-
PAGE gel to ensure that the protein was produced and soluble. Soluble protein in the supernatant 
was purified via affinity chromatography using Glutathione Sepharose 4B GST-tagged protein 
purification resin (GE Healthcare Life Sciences, Marlborough, MA), followed by elution with 50 
mM tris-HCl, 10 mM glutathione and dialysis against PBS, yielding concentrated rFapC217-938. 
Purified protein was verified via SDS-PAGE for correct size and purity. Purified protein was 
quantified by measuring absorbance at 280 nm.  
Saliva Binding Assays 
Saliva (Lee Biosciences, Maryland Heights, Mo) was clarified by centrifugation of 1.2 mL of 
whole saliva at 21,000 g at 4 oC for 20 minutes. The supernatant was separated and filter 
sterilized. Assays were conducted in 96-well plates. To coat plates, saliva was diluted 5X in PBS 
and 100 µL of diluted saliva was used per well. Plates were left at 4 oC overnight and then 
washed twice with 120 µL PBS to remove non-adherent saliva. Bacterial cultures were grown to 
OD600 = 0.300 ± 0.005 and diluted 25X in PBS. 50 µL of diluted bacterial culture was added per 
well followed by incubation at 37 oC for one hour. Non-adherent bacteria were removed by 
washing three times with 120 µL PBS. Adherent bacteria were lifted with 100 µL of 0.25% 
trypsin/1 mM EDTA at 37 oC for fifteen minutes. Bacteria were enumerated by serial dilution 
from 100 to 10-3 and plating. All binding assays were performed three times in triplicate. 




For experiments involving neuraminidase treated saliva, saliva was diluted 5X in PBS followed 
by addition of Clostridium perfringens neuraminidase to a concentration of 0.1 U/mL. Saliva 
was neuraminidase treated for 14-16 hours in a 37 oC water bath, followed by coating according 
to the protocol outlined above. Where appropriate, binding assays were performed in the 
presence of recombinant FapC non-repeat region (rFapC217-938) at a final concentration of 5-7 
µM or 1 mM free N-acetylneuraminic acid.   
Auto-aggregation Assays 
S. oralis subsp. dentisani strains were grown in THY to OD600 = 0.600 ± 0.005 and cells were 
harvested by centrifugation at 5000 rpm at 4 oC for 15 minutes. Cells were washed using 0.15 M 
NaCl twice and resuspended in 0.15 M NaCl to 1/10 of the original volume. 250 µL of the 
bacterial suspension was added to 1.75 mL of 0.15 M NaCl in a 250 mL Erlenmeyer flask and 
subsequently shaken at 200 rpm at 37 oC for 2 hours. OD600 was measured directly following 
incubation. Aggregation assays were performed three times. Significance was determined via a 










Table 1: Strains used in this study  
Strain or plasmid Characteristic(s)/genotypea Source or reference 
Strain 
S. oralis subsp. dentisani 
    
F0392 Originally identified as Streptococcus mitis isolated 
from the human oral cavity 
BEI resourcesb  
F0392 ΔsecA2 ΔsecA2::aad9, Spcr  This study 
F0392 ΔfapA  ΔfapA::erm, Ermr This study 
F0392 ΔfapB ΔfapB::kan, Kanr This study 
F0392 ΔfapC ΔfapC::aad9, Spcr This study 
F0392 ΔfapB ΔfapA ΔfapB::kan ΔfapA::erm, Kanr Ermr This study 
F0392 ΔfapC ΔfapA ΔfapC::aad9 ΔfapA::erm, Spcr Ermr  This study 
F0392 ΔfapC ΔfapB ΔfapC::aad9 ΔfapB::kan, Spcr Kanr This study 
F0392 ΔfapC ΔfabB ΔfapA ΔfapC::aad9 ΔfapB::kan ΔfapA::erm, Spcr Kanr 
Ermr 
This study 
F0392 Smr Lys56 → Thr mutation in RpsL [rpsL(K56T)] 
conferring Smr 
This study 
F0392 FapC R837E Janus ΔfapC::kan/rpsL+ rpsL(K56T), Kanr Sms This study 
F0392 FapC R837E Arg → Glu mutation in FapC [fapC(R837E)]; 
rpsL(K56T) Smr 
This study 
F0392 FapC R837M Arg → Met mutation in FapC [fapC(R837M)]; 
rpsL(K56T) Smr 
This study 
      
Escherichia coli     
Stellar  Cloning Host  Takara  
BL21 (DE3) Expression Host NEB 
      
Plasmids      
pDrive  Cloning vector; Ampr Kanr Qiagen 
pDriveΔsecA2 pDriveΔsecA2::aad9 Spcr Ampr Kanr This study 
pJET1.2/blunt Cloning vector; Ampr Thermo Fisher 
Scientific 
pJETΔfapA pJetΔfapA::erm, Ermr Ampr   This study 
pJETΔfapB pJetΔfapB::kan, Kanr Ampr   This study 
pJETΔfapC pJetΔfapC::aad9, Spcr Ampr  This study 
pGex-5x-3 Expression vector; Ampr GE Biosciences 
pGex-5x-3 FapC Janus pGex-5x-3 FapCR837E with Janus cassette; Ampr, 
Kanr 
This study 
pGex-5x-3 FapCR837E pGex-5x-3 containing fapC 722-938 with Arg → 
Glu mutation in FapC [fapC (R837E)]; Ampr 
This study 
pGex-5x-3 FapCR837M pGex-5x-3 containing fapC 722-938 with Arg → 




pGex-5x-3 FapC217-938 pGex-5X-3 containing FapC 217-938; Ampr  This study 
a Spcr, spectinomycin resistant; Kanr, kanamycin resistant; Ermr, erythromycin resistant, Ampr, 
ampicillin resistant; Smr, streptomycin resistant. 
b Strain F0392, HM-262 was obtained through BEI Resources, NIAID, NIH as part of the 






















Table 2: Primers used in this study 
Target or 
Group 
Name Sequence 5' to 3' Location  
(accession no.) 
secA2 E.i  TCGGATCCAGAATTCTCAGATTGCAGAAATGAGAACa 944658-944678 
(CP034442)  
E.ii CACGAACGAAAATCGATCTGGATCATAGGCATTCTGb 944102-944122 
(CP034442)  
E.iii ATAAACCCTTGCATAATTCATTTGACCTCTCGTCGb 943218-943237 
(CP034442)  
E.iv CTTGTCGACGAATTCAACAGTCATCTATCGCTCTCa 942780-942800 
(CP034442)  
E.5 ACTAAACGATTCAATTTGAC 944931-944950 
(CP034442)  
E.6 TAATGTAACTCAATGCCATG 942610-942629 
(CP034442) 
fapA A.1 ATTTGATGCGGACGAATATC 933128-933147 
(CP034442)  
A.3 TAGGTTTCATTGACTGTATC 932764-932783 
(CP034442)  
A.4 TGAGGTTTGTTCAAGGAGTGG 932645-932665 
(CP034442)  
A.2 AGTAACTGTTAATCCAAGAGC 932253-932273 
(CP034442)  
A.5 GGTGTTCCTTTCTCGG 933173-933188 
(CP034442)  
A.6 AGTTAAGCTGTCCAGCTTCG 932123-932142 
(CP034442)  
A.7 ACCTGCTGTAACGTATGATG 932834-932853 
(CP034442)  
A.8 TAGCATTTCTAGCATCTTGC 932711-932730 
(CP034442)  
A.9 AAGGAGCAAGAACCAGCAAAAC 917963-917984 
(CP034442)  
A.10 TTGTGAGAATGGCGATGAGAAT 917838-917859 
(CP034442) 
fapB B.1 TGCAGGATTTGTGATGACTC 1826328-1826347 
(CP034442)  
B.3 GCAGGGTTGACCTTAAGGTTG 1826847-1826867 
(CP034442)  
B.4 AGCAACAATATCGCAGCTGG 1826944-1826963 
(CP034442)  
B.2 TCCGTACTTGCACAACATCC 1827339-1827358 
(CP034442)  
B.5 TCTAGTACCCTATCAGACAC 1826236-1826255 
(CP034442)  
B.6 ATTGACCACTCCTTGACCAC 1827464-1827483 
(CP034442)  
B.7 ACAAGCGCAGCTCTTAGCAC 1826905-1826924 
(CP034442)  





B.9 AGCTACATCAAGCGTCTCCATG 1841859-1841880 
(CP034442)  
B.10 CGAACTTTGTGAGCCAAGATTG 1841995-1842016 
(CP034442) 
fapC C.1 ACCTAGCAGCTGGTGTGATC 761428-761447 
(CP034442)  
C.3 TTGTTTAGCAGTGACTTCTG 761053-761072 
(CP034442)  
C.4 TATTGTGTACGCAGGAGACG 760059-760078 
(CP034442)  
C.2 AACGGCTGCTAATATACGTG 759619-759638 
(CP034442)  
C.5 ATCCCTTGATGTCAAGACTG 761538-761557 
(CP034442)  
C.6 TAGTAATCGTATCCGTAGTC 759513-759532 
(CP034442)  
C.7 TTTCAGCTGAAAGATTGGTC 761010-761029 
(CP034442)  
C.8 ACCTTGAAATTGACTCAGCTG 761178-761198 
(CP034442)  
C.9 GGGTGTGGAAGGCTATGTTGAG 745835-745856 
(CP034442)  
C.10 CGCTGTGGTCTCTGGGAAGAT 745748-745768 
(CP034442)  
C.11 GGTCGTGGGATCCCA GTGGATGCTGTTCCAGTTCCAAGc 760130-760152 
(CP034442)  
CG.12 GCCTTATCCGTTGCTACTGCATTCTCTTGCCAACTATTTCTACCATTTTd 759782-759830 
(CP034442) 
 CG.13 AAAATGGTAGAAATAGTTGGCAA GAGAATGCAGTAGCAACGGATAAGGCd 759782-759830 
(CP034442)  
CM.12 GCCTTATCCGTTGCTACTGCATTCATTTGCCAACTATTTCTACCATTTTd 759782-759830 
(CP034442) 
 CM.13 AAAATGGTAGAAATAGTTGGCAAATGAATGCAGTAGCAACGGATAAGGCd 759782-759830 
(CP034442) 
 C.14 ATGCGGCCGCTCGAGTTATTAGAAAGTTTTATAGTAATCGc 759502-759521 
(CP034442) 
 C.15 AGTAGCAACGGATAAGGCTG 759780-759799 
(CP034442)  
C.16 TTGCCAACTATTTCTACCAT 759808-759827 
(CP034442) 
 C.17 GGTCGTGGGATCCCA GCTCAACCTGCTCCTTCAGTc 761648-761667 
(CP034442) 




aad9 S.F CGATTTTCGTTCGTGAATAC 5418–5399  
(KM009065)  
S.R TATGCAAGGGTTTATTGTTTTC 4265–4286  
(KM009065) 
erm E.F CTCGAGCGGCCGCCAGTG 264–282  
(EU233623)  
E.R AACGGCCGCCAGTGTGCTG 319–336  
(EU233623) 
Janus J.F CCGTTTGATTTTTAATGGATAATG 773–796  
(AF411920.1) 






rpsL R.F CGGTACTTTTTACTTTTGGTCTCTC 1709537-1709561 
(CP034442) 
 R.R TCTTTATCCCCTTTCCTTATGC 1710075-1710096 
(CP034442)     
    
aUnderlining indicates nucleotides introduced to allow In-fusion cloning into the pDrive vector. 
bUnderlining indicates nucleotides introduced to allow In-fusion cloning with aad9 
(spectinomycin cassette). 
cUnderlining indicates nucleotides introduced to allow In-fusion cloning with pGex-5X-3 vector. 




















Electron microscopy images of Streptococcus oralis subsp. dentisani reveal dense mono-
lateral fibrils 
Electron microscopy of the S. oralis subsp. dentisani strain F0392 revealed dense mono-lateral 
fibrils which appeared to be of different lengths (Fig. 1). F0392 had previously been classified as 
S. mitis biovar 2 but has been reassigned to S. oralis subsp. dentisani by multilocus sequence 
analysis (MLSA) (9). Fibrils appeared to be composed of two different lengths, the shorter of 
which being approximately 300-350nm and the longer being approximately 500 nm.  
This distribution of surface fibrils is similar to that seen on Streptococcus cristatus strains CR311 
and CC5A, which also displayed mono-lateral fibrils of multiple lengths (23, 25). The long 
fibrils of S. cristatus have been linked with the SRRP SrpA.  
 
 
Genome sequencing reveals three putative serine-rich repeat proteins  
We sought to determine whether S. oralis subsp. dentisani F0392 contains genes which may 
encode for SRRPs. The non-contiguous F0392 genome revealed three potential genes which may 
encode for SRRPs; however, these sequences contained stop codons and were distributed 
Figure 1. STEM images of Streptococcus oralis subsp. dentisani isolate 
F0392 bound to a formvar-coated grid and stained with 1% ammonium 





amongst multiple contigs, making it difficult to confirm their validity. Full genome sequencing 
of S. oralis subsp. dentisani strain F0392 was generated via PacBio technology, which is more 
capable of accurately sequencing large repeat sequences than the Illumina technology used to 
sequence this genome previously. Genomic analysis confirmed the presence of the three putative 
SRRPs open reading frames originally seen in the non-contiguous sequence. Because we predict 
these genes are associated with the surface fibrils on this bacterium, we have named them fapA 
(13992 bp), fapB (13692 bp) and fapC (15144 bp) for “fibril associated protein” (Fig. 2).   
 
   
Each of these three open-reading frames is predicted to encode a protein containing the 
conserved features of previously identified SRRPs, including an atypical N-terminal signal 
sequence, a cell wall anchor domain and two serine-repeat regions which flank a non-repeat 
region (13, 17, 23, 32, 40-45). The atypical N-terminal signal sequence is responsible for 
secretion of the protein via the accessory secretion system (SecA2/Y2) and is generally 
Figure 2. Schematic of loci encoding putative SRRPs in S. oralis subsp. dentisani strain F0392. Open reading 
frames are indicated by block arrows. Genes predicted to encode proteins of known function are labeled with 
gene names, if known, or predicted function.               
     Indicates predicted terminators and      indicates predicted promoters. 
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approximately 90 amino acids long (41). The putative SRRPs encoded for within S. oralis subsp. 
dentisani F0392 contain predicated signal sequences of 93 amino acids in length, which are 
highly conserved between the three SRRPs, showing 100% amino acid identity between FapA 
and FapB and 93.5% identity with FapC. The N-terminal sequence similarity between FapA and 
FapB extends past this region, having 80% identity and 82% similarity between the first 338 
amino acids of FapA and the first 348 amino acids of FapB. FapC does not share this similarity 
with either FapA or FapB apart from the atypical signal sequence.  
It is also important to note that fapA is located at the 3’ end of an operon which also contains 
genes encoding for proteins responsible for glycosylation and secretion of the SRRP. The regions 
containing fapB and fapC do not contain any other genes related to SRRPs (Fig. 2).  
Predicted SRRP contribution to observed surface fibrils 
In order to determine whether the surface fibrils of F0392 were dependent upon one or more of 
the predicted SRRP encoding genes, we took advantage of the accessory secretion system 
specific for secretion of SRRPs. An insertion-deletion mutant was generated which lacked secA2, 
the gene which encodes for the ATPase which energizes SRRP transport across the membrane 
(27, 40). This mutant lacks all fibrils, supporting the hypothesis that these fibrils are SRRPs and 
SecA2 dependent (Fig. 3). Single, double and triple mutants were then generated in order to 
determine the contribution of each open-reading frame to the presence of surface fibrils. Imaging 
of double mutants revealed that each of the mutants retained presence of surface fibrils, 
suggesting that all three of the putative SRRPs are produced. Interestingly, each of the three 
SRRPs yielded a different density and distribution of surface fibrils across the occupied side 
(Fig. 3). The mutant expressing only FapB (F0392 ∆fapC∆fapA) displayed fibrils which were 




also displayed fibrils resembling the parent, however, these fibrils appeared less dense than those 
of the parental strain. The fibrils on the FapC expressing mutant (F0392 ∆fapB∆fapA) were 
mostly concentrated toward the poles of the cells and localized on the oldest cells in the chain 
(data not shown).  A triple mutant, F0392 ∆fapC∆fapB∆fapA, was devoid of surface fibrils, 




Predicted SRRP functions  
In order to determine possible functions of FapA, B and C, the amino acid sequences of the NRR 
of each SRRP were compared against NRR sequences of known SRRPs with identified catalytic 
domains and functions (Fig. 4).  
Figure 3. Three SRRPs contribute to production of fibrils on the surface of S. oralis subsp. 
dentisani strain F0392. STEM images of the parental strain, F0392, and the generated mutants 
bound to a formvar-coated grid and stained with 1% ammonium molybdate. Strain names are above 
the panels in black and the SRRPs still expressed in each double mutant are given in grey (scale bar, 







The NRR of FapA shared 90% amino acid identity and 93% similarity with the SRRP SrpA from 
S. cristatus CC5A. srpA dependent fibrils have been implicated in being necessary for the 
formation of ‘corncob’ structures with species such as Corynebacterium matruchotti and 
Fusobacterium nucleatum, although the specific receptor involved in this interaction is unknown 
(23-25). Corncob structures are prominent in dental biofilms and are thought to anchor the non-
streptococcal structures to the tooth surface (46-48). Sequence similarity between SrpA and 
FapA suggests FapA may play a role in interspecies interactions such as corncob formation. 
Additionally, we have identified an open reading frame in S. cristatus CR311 which encodes for 
a protein that shares 93% identity and 95% amino acid similarity with the FapC NRR.   
HHpred, a server which detects homologs using structural information, identified structural 
similarity between FapA and S. parasanguinis SRRP Fap1 (97.8% probability, E-value 8.5x10-8) 
(PDB ID: 2X12) (31, 49). Fap1 contains two catalytic domains which have both been shown to 
Figure 4. Schematic illustration of the putative domains within the NRR of S. oralis subsp. dentisani F0392 SRRPs. 
Domains identified by HHpred, a server for remote homolog detection, are labeled. The numbers above the 
schematics indicate the predicted boundaries of the domains. There were small differences in the boundaries 
predicted for the domains within FapC using structures of S. gordonii GspB and S. sanguinis SrpA. The boundaries 
provided here are from the prediction using SrpA. In addition, the boundaries identified resulted in an overlap of 
seven amino acids (722-729) between the first unique domain and second Siglec domain. 
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contribute to adhesion, α (aa 129-206) and β (aa 237-425) (31). These domains are conserved in 
the NRR of FapA (Fig. 4). Because FapA and FapB share N-terminal sequence similarity, there 
is also some sequence similarity between their NRRs and therefore some predicted structural 
similarity between the two regions. Thus, FapB also shares predicted structural similarity with S. 
parasanguinis Fap1, covering the Fap1 α domain (92% probability, E-value 4.5x10-3) (PDB ID: 
2KUB) (31) (Fig. 4). The 3’ region of the FapB NRR also shares some predicted structural 
similarity with the C-terminal region of the Fap1 β domain (65.2% probability, E-value 4.6) 
(PDB ID: 2X12). S. parasanguinis Fap1 has been shown to be required for efficient binding to 
saliva coated hydroxyapatite and biofilm formation, suggesting a role for FapA and FapB in 
these functions (32, 33, 50).  
FapC was predicted to share structural similarity with sialic acid binding immunoglobulin- like 
lectins (Siglecs) and unique domains from S. sanguinis and S. gordonii (PDB IDs: 3QC5 and 
5KIQ) (>99% probability, E-value > 1x10-14) (49, 51, 52). Interestingly, FapC contains two of 
each of these domains (Fig. 4). S. sanguinis SK1 has been reported to also contain two of each of 
these domains, however only one of the two Siglecs was predicted to contain the active arginine 
residue necessary to bind sialic acid in other bacterial Siglecs (51, 53, 54). This is also the case in 
FapC.  It is unknown whether the other Siglec domain in SK1 or FapC, which lacks the predicted 
active arginine residue, contributes to adhesion. However, the NRR of SK1 has been shown to 
bind sialic acid, implicating a role for FapC in sialic acid binding (53). 
FapC is necessary for effective adherence to saliva  
As sialic acid is a widely distributed host receptor and would be important in both oral 
colonization and infective endocarditis, we sought to determine the ability of this bacterium to 




domains. Study of adherence to immobilized saliva was chosen as saliva is heavily sialylated and 
it is unlikely that bacterial adhesion to free sialic acid plays a role in colonization or infection 
(55). F0392 ∆fapC showed a significant reduction (>90%) in adherence relative to the parental 
strain, suggesting FapC does bind sialic acid (Fig. 5A). A second independent FapC mutant was 




To further study this interaction, a point mutant, F0392 FapCR837E, was generated in which the 
predicted active arginine residue was changed to glutamic acid. As this change has previously 
been shown to eliminate sialic acid binding in other SRRPs, we expected this point mutant to 
bind saliva less efficiently than the parent (52-54). Interestingly, an increase in saliva binding 
was observed for the F0392 FapCR837E mutant compared to the wild type (Fig. 5B). As FapA 
contains two predicted Siglec domains within its NRR, it possible that there is a residue within 
the other Siglec domain that is able to bind to sialic acid.  
Figure 5. The contribution S. oralis subsp. dentisani strain F0392 SRRP FapC to saliva binding. FapC is 
required for efficient binding to saliva (A). However, mutation of a conserved arginine residue shown in other 
Siglec domains to be required for sialic acid binding increases adhesion (B). Adhesion is expressed as a 
percentage relative to that of the parental strain. Values are the mean of at least three independent experiments 
each performed in triplicate ±SD. Statistical significance was tested by a two-tailed Student’s t test; *, P ≤ 0.01. 
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To determine whether the interaction between F0392 FapC and saliva was direct, the NRR of 
FapC was recombinantly expressed and used to test if addition of this region would 
competitively inhibit binding of F0392. Results show that addition of recombinant FapC217-938 
does reduce adherence of F0392 to levels similar to that of F0392 ∆fapC (Fig. 6). Furthermore, 
adherence of F0392 ∆fapC was not further reduced by the addition of recombinant FapC217-938. 





In order to better understand whether FapC was binding sialic acid, saliva adherence assays were 
conducted in which saliva was pre-treated with Clostridium perfrigens neuraminidase in order to 
Figure 6 
Figure 6.  Adhesion of F0392 FapC to saliva is a direct interaction. “+” indicates trials in which 5-7 µM 
rFapC
217-938
 was added. Adhesion is expressed as a percentage relative to that of the parental strain. Values 
are the mean of at least three independent experiments each performed in triplicate ±SD. Statistical 
significance was tested by a two-tailed Student’s t test; *, P ≤ 0.01; ns, not significant.    
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cleave terminal sialic acid receptors present on saliva. Somewhat unexpectedly, binding of 
F0392 to neuraminidase treated saliva was not significantly different from binding to untreated 
saliva (Fig. 7). These data seem to suggest that the SRRPs produced by this strain are able to 




To further study whether FapC was binding sialic acid, blocking assays were conducted in which 
free sialic acid was added to saliva binding assays to test its ability to block interactions between 
saliva and FapC. Results show that there is no significant difference in saliva binding when sialic 
acid is added (Fig. 8). This may indicate that F0392 not able to bind free sialic acid. 
Figure 7 
Figure 7. Cleavage of terminal sialic acid does not decrease adhesion of F0392 to bound saliva as predicted. This 
suggests that SRRPs of F0392 may be able to bind carbohydrates underlying sialic acid. Adhesion is expressed as a 
percentage relative to that of the parental strain. Values are the mean of at least three independent experiments each 






As FapA and FapB are predicted to play a part in intraspecies interactions, auto-aggregation 
assays were conducted in order to test their role in F0392 aggregation. Results showed that 
FapA, FapB and FapC may to contribute to the ability of F0392 to aggregate. F0392 ∆fapA, 
F0392 ∆fapC∆fapB, F0392 ∆fapB∆fapA and F0392 ∆fapC∆fapB∆fapA all show significantly 
less aggregation than the parental strain. Aggregation of F0392 ∆fapB was not significantly 
different from the parental strain, however given that aggregation of the fapB mutant was 
reduced in each of three experiments, we predict further testing will show this difference is 
significant. Each of the three double mutants showed significantly higher aggregation than the 
triple mutant, indicating that the presence of any one SRRP may be enough to cause aggregation 
to some degree. Significant differences between the double mutants expressing FapA or FapB 
and the double mutant expressing FapC show that the relative contributions of each of the 
Figure 8 
Figure 8. Addition of free sialic acid does not significantly impact adhesion of F0392 to saliva. Adhesion is 
expressed as a percentage relative to that of the parental strain. Values are the mean of at least three independent 
experiments each performed in triplicate ±SD. Statistical significance was tested by a two-tailed Student’s t test; ns, 
not significant.  
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In this study, we have identified a Streptococcus oralis subsp. dentisani oral isolate (F0392) 
which produces three serine-rich repeat proteins, resulting in the formation of dense mono-lateral 
fibrils on the cell surface. We have demonstrated that one of these proteins, FapC, is necessary 
for efficient binding to saliva and a combination of these proteins appear to play a role in auto-
aggregation. 
Although it is unusual for streptococcal strains to express more than a single SRRP, there have 
been other cases of the expression of multiple SRRPs similar to S. oralis subsp. dentisani. 
Streptococcus salivarius has been shown to also express three SRRPs, although these SRRPs are 
distributed evenly across the bacterial surface (13). Mono-lateral fibrils of multiple lengths have 
also been observed on S. cristatus strains CR311 and CC5A. The longer one of these fibrils has 
been correlated to the SRRP SrpA (23, 25). We have also identified an additional SRRP 
encoding gene within the CR311 genome (AFUE01000008). The 90% amino acid identity and 
Figure 
9 
Figure 9.  FapA and FapB contribute to auto-aggregation of F0392. Aggregation is measured by absorbance at 600 nm post 2-
hour incubation while shaking. Values are the mean of at least three independent experiments ±SD. Statistical significance was 
tested by a two-tailed Student’s t test; *, P ≤ 0.05.  
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93% similarity between the NRRs of FapA and the S. cristatus SRRP SrpA as well as the 93% 
amino acid identity and 95% similarity between the NRR of FapC and a putative protein of S. 
cristatus CR311 suggests there may have been multiple recombination events between these two 
species (9). S. cristatus is not as closely related to S. oralis subsp. dentisani as some other 
organisms, making it likely that these species have undergone horizontal gene transfer, as they 
are the only two identified streptococci with mono-lateral fibrils.  
The same study which identified mono-lateral fibrils of S. cristatus also described mono-lateral 
fibrils for S. oralis; however, because of changes in classification of this species, it is unclear 
whether this is the same S. oralis described today (23). Additionally, some Geobacter species, 
including G. metallireducens, produce mono-lateral pili on the surface of their cells (56). The 
mechanism of fibril/pili localization for these species is unknown. The FapA encoding locus also 
contains genes encoding for proteins responsible for glycosylation and secretion of SRRPs. We 
hypothesize that genes in this locus may be controlling the distribution of the accessory secretion 
system, SecA2/Y2, thus producing this mono-lateral distribution.   
Imaging of F0392 double mutants, which only express a single SRRP, showed observable 
differences in the distribution of each fibril on the bacterial surface (Fig. 3). The mechanism for 
this difference in distribution is unknown, although we hypothesize it may be due to differences 
in timing and/or levels of fap gene expression, as well as the conditions required for secretion via 
the accessory Sec system. Although the mechanism is not yet known, we believe the presence of 
differentially distributed surface fibrils on all three double mutants indicates that each SRRP 
produces a distinct fibril, although we cannot rule out the possibility that fibrils observed on the 
parental strain consist of more than one fibrillar protein. Images of the parental strain showed 
fibrils which appeared to be of two different lengths, leading us to believe that at least one of the 
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SRRPs produce a longer fibril; however, the double mutants did not appear to show any 
differences in length between fibrils (Fig. 3). It is possible that the decrease in fibril density of 
the double mutants caused less stain to be trapped, making it more difficult to visualize fibrils 
which are further from the bacterial surface. Alternatively, fewer fibrils may relax the physical 
constrains the fibrils place on each other, thus allowing them to extend further from the bacterial 
surface.  
All identified functions of SRRPs have centered on bacterial adhesion through the proteins non-
repeat region. We hypothesize that these proteins play a major role in the ability of S. oralis 
subsp. dentisani to colonize the oral cavity, as this species is adapted to colonize this 
environment. Study of sequence similarity between the NRR of FapA and the NRR of other 
known SRRPs suggests that FapA mediates interspecies interactions. Structural predictions of 
the NRR reveal that FapA and FapB may contribute to biofilm formation, while FapC may 
contribute to sialic acid binding.  Structural prediction identified two putative Siglec and unique 
domains in the FapC NRR. These domains have been known to be required for sialic acid 
binding in other SRRPs (17, 52, 53, 57, 58). We chose to further study the role of FapC to sialic 
acid binding as sialic acid is a widely distributed host receptor and would likely play a role in 
oral colonization, as many tooth and other oral surfaces are coated in salivary glycoproteins 
which are often heavily sialylated. Only one of the two putative Siglec domains in the FapC 
NRR contains the predicted active arginine residue reported to be critical in sialic acid binding 
(51, 53, 54). Previous studies have shown that mutation of this residue to glutamic acid 
eliminates sialic acid binding (51, 53, 54). However, mutation of this residue in FapC actually 
caused an increase in adherence (Fig. 5). It is proposed that this arginine residue facilitates 
adhesion by hydrogen bonding with the glycerol group of sialic acid (59). As glutamic acid is 
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capable of hydrogen bonding, it is possible that the binding pocket can accommodate this change 
and still position the ligand correctly to allow hydrogen bonding. Substantiating this, hydrogen 
bonding between sialic acid glycerol and an acidic residue has been observed, including viral and 
bacterial neuraminidases (60, 61). Another member of the lab generated and tested adherence of 
an arginine to methionine point mutant to assess this theory, however, there was no significant 
change in adherence, leaving much of the mechanism of this interaction unclear.  
Although FapA and FapB are predicted to share structural similarity with S. parasanguinis SRRP 
Fap1, which was required for efficient binding to saliva coated hydroxyapatite and biofilm 
formation (32, 33, 50). The large decrease in adherence of the FapC mutant indicates that if 
FapA or FapB contribute to saliva binding, this contribution must be relatively small. However, 
FapA or FapB may bind carbohydrates underlying sialic acid. The non-significant difference in 
adherence to neuraminidase treated saliva suggests that F0392 is able to bind carbohydrates 
underlying sialic acid (Fig. 7). It is unclear as to whether one or multiple SRRPs produced by 
F0392 are able to bind underlying carbohydrates, but strains producing sialic acid binding 
SRRPs have been shown to also bind cryptic β-1,4 linked galactose exposed by endogenous 
neuraminidase (17, 18).  
Sialic acid blocking has previously been shown to decrease adherence of sialic acid binding 
SRRPs to platelets (17). It was thus surprising that adherence of F0392 was not significantly 
reduced by addition of free sialic acid (Fig. 8). However, this does not eliminate the possibility 
that FapC is binding sialic acid. It is possible that FapC is unable to bind free sialic acid, but 
rather requires sialic acid to be a terminal receptor on a chain of carbohydrates or only binds 
particular linkages of sialic acid.     
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Upon testing of interspecies interactions of F0392 wild-type and mutant strains, we noticed 
differences in aggregation of the F0392 wild-type and triple mutant control groups. This led to 
the hypothesis that the fibrils may be impacting the ability of this bacterium to auto-aggregate. 
As predicted domains in FapA and FapB are thought to be involved in intraspecies interactions, 
we designed an auto-aggregation assay to test the ability of each mutant to aggregate. FapA and 
FapB seem to be the primary contributors to this interaction. The significant reduction in 
aggregation from the parental strain to the FapA mutant implicates this protein in aggregation. 
Although the change in aggregation between the parental strain and the FapB mutant was not 
significant, we expect that further testing will show that removal of FapB does result in a 
significant decrease in aggregation. The involvement of FapA and FapB is further supported by 
the significantly higher aggregation of the double mutants which only express FapA or FapB 
compared to the FapC expressing double mutant. This would suggest that if FapC only plays a 
role in aggregation when it is the only SRRP present. Furthermore, significant differences 
between each of the double mutants and the triple mutant suggests that removal of either FapA, 
FapB or FapC impacts aggregation, with removal of FapC appearing to have the smallest effect. 
Finally, the non-significant difference between the parental strain and FapB expressing mutant 
suggests FapB alone may be enough to cause aggregation. The exact contribution of FapA, FapB 
and FapC to F0392 auto-aggregation is unclear, but these data suggest that FapA and FapB both 
likely play a role.  
Through this work we have established that S. oralis subsp. dentisani produces dense mono-
lateral fibrils. Our data supports our hypothesis that this organism produces three distinct fibrils 
of different distributions across the cell surface, each of which is linked to a SRRP. Although the 
exact function of each of these SRRPs is unknown, predicted domains suggest they each play a 
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unique role in bacterial adhesion. We have shown that at least one of these SRRPs is necessary 
for efficient binding to saliva, and others appear to influence auto-aggregation. As the mono-
lateral distribution of fibrils and expression of multiple SRRPs is a relatively unstudied 
phenomenon, more work will need to be done in order to better understand the functions of these 
proteins and the effect of their distribution on cell biology before we can begin to understand 
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